ArticlePloS one2026
Anomaly detection of cybersecurity behavior using cross-sequence aligned transformer-A dynamic recognition approach for high-frequency interaction patterns.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In high-frequency interaction network environments, network traffic features and user behavior sequences often exhibit pronounced temporal asynchrony and information redundancy, which can substantially weaken the capability of anomaly detection models to identify dynamic attack patterns. Based on this observation, this study proposes and empirically validates a core hypothesis: explicitly modeling the temporal asynchrony among multi-source sequences and performing collaborative modeling on a unified temporal scale can effectively enhance the accuracy and stability of cybersecurity anomaly detection under high-frequency interaction scenarios. To verify this hypothesis, a Cross-Sequence Aligned Transformer-driven Dynamic Recognition Model (CSAT-DRM) is developed, which falls within the category of deep learning-based multimodal time-series anomaly detection frameworks. The proposed model employs a cross-sequence alignment mechanism to softly align network traffic sequences and user behavior sequences, capturing their latent correlations without compressing inherent temporal discrepancies. Meanwhile, an interaction-sensitive residual structure is introduced into the Transformer encoding process to enhance the discriminability of anomalous features under high-frequency interactions, and a dynamic threshold generation strategy is integrated to enable adaptive anomaly discrimination. Experiments are conducted on real-world network interaction log data and evaluated through multiple baseline models and five independent repeated runs. The results show that CSAT-DRM achieves an accuracy of 0.968 ± 0.004, a precision of 0.957 ± 0.005, a recall of 0.953 ± 0.006, and an F1-score of 0.955 ± 0.005 on the test set, significantly outperforming baseline approaches including Long Short-Term Memory (LSTM), Convolutional Neural Networks (CNNs), the standard Transformer, and the hybrid Convolutional Neural Network-Bidirectional Long Short-Term Memory (CNN-BiLSTM) model. Further analysis demonstrates that the proposed model can effectively detect both burst anomalies and persistent anomalies, while maintaining high stability across different anomaly types. These findings validate the effectiveness of cross-sequence alignment and adaptive discrimination mechanisms in high-frequency interaction network anomaly detection, providing a feasible and generalizable technical pathway for real-time threat identification in complex network environments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.